section 8
on 05 May 2023
Last Applicant/ Owned by
Robert-Roessle-Str. 10, Building D80
Berlin
DE
13125
Serial Number
86919081 filed on 25th Feb 2016
Registration Number
5067522 registered on 25th Oct 2016
Correspondent Address
CELARES GMBH
Filing Basis
No Filing Basis
Disclaimer
NO DATA
The mark consists of the letters "P a S m a x" with the letters "max" being superscript. The mark is black and white. Active chemical ingredients and solvents for use in the manufacture of insecticides; Active chemical ingredients for use in the manufacture of anti-cancer drugs; Chemicals for use in biotechnological product development; Chemicals for use in biotechnological manufacturing processeRead More
Chemical laboratories; Chemical research; Drug discovery services; Pharmaceutical drug development services; Pharmaceutical research and development; Pharmaceutical research services; Conducting early evaluations in the field of new pharmaceuticals; Consulting services in the fields of biotechnology, pharmaceutical research and development and genetic science; Consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; Development of pharmaceutical preparations and medicines; Development of pharmaceutical preparations and medicines; Laboratory research services relating to pharmaceuticals; Pharmaceutical drug development services; Research and development in the pharmaceutical and biotechnology fields; Research in the field of Antibody drug conjugates
Active chemical ingredients and solvents for use in the manufacture of insecticides; Active chemical ingredients for use in the manufacture of anti-cancer drugs; Chemicals for use in biotechnological product development; Chemicals for use in biotechnological manufacturing processes
Chemical reagents for medical or veterinary purposes; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system; Pharmaceutical preparations for the treatment of inflammatory disorders; Pharmaceutical preparations for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; Pharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosis; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations, namely, antivirals; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; Cytostatics for pharmaceutical purposes; Drug delivery agents in the form of molecular solubility enhancer that facilitate the delivery of pharmaceutical preparations; Pharmaceutical preparations, namely, a blood clotting aid and delivery system for use in human and veterinary medicine
No 86919081
No Service Mark
No
No
No
No
No
No
No
No
No
The mark consists of the letters "P a S m a x" with the letters "max" being superscript. The mark is black and white.
| Status Date | Action Taken |
|---|---|
| 05th May 2023 | CANCELLED SEC. 8 (6-YR) |
| 25th Oct 2021 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED |
| 25th Oct 2016 | REGISTERED-PRINCIPAL REGISTER |
| 09th Aug 2016 | PUBLISHED FOR OPPOSITION |
| 09th Aug 2016 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 20th Jul 2016 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 02th Jul 2016 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
| 27th Jun 2016 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| 25th Jun 2016 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| 25th Jun 2016 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
